Metropolis Healthcare (BOM:542650) EBIT : ₹1,972 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare EBIT?

Metropolis Healthcare's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ₹561 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,972 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Metropolis Healthcare's annualized ROC % for the quarter that ended in Mar. 2024 was 11.31%. Metropolis Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 63.50%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Metropolis Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 1.91%.

Metropolis Healthcare EBIT Historical Data

The historical data trend for Metropolis Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare EBIT Chart

Metropolis Healthcare Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT

Get a 7-Day Free Trial

1,770.78

2,521.05

3,130.93

2,143.05

1,972.25

Metropolis Healthcare Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															480.78	451.71	537.90	421.62	561.01

Competitive Comparison of Metropolis Healthcare's EBIT

For the Diagnostics & Research subindustry, Metropolis Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metropolis Healthcare's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Metropolis Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Metropolis Healthcare's EV-to-EBIT falls into.

Metropolis Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,972 Mil.

Metropolis Healthcare (BOM:542650) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Metropolis Healthcare's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	2142.48 * ( 1 - 27.72% )	/	( (0	+	13693.922)	/ 1 )
=	1548.584544	/	13693.922
=	11.31 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0	-	( 0	-	max(0, 0	-	0	+	0	))
=	0

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	15550.626	-	1157.149	-	( 1305.749	-	max(0, 2458.742	-	3158.297	+	1305.749	))
=	13693.922

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Metropolis Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	2244.056	/	( ( (0 + max(0, 0))	+	(3360.34 + max(173.773, 0)) )	/	1 )
=	2244.056	/	( ( 0	+	3534.113 )	/	1 )
=	2244.056	/	3534.113
=	63.50 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1262.812	+	386.936	+	202.8)	-	(1157.149	+	0	+	521.626)
=	173.773

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Metropolis Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	1972.247	/	103166.052
	=	1.91 %

Metropolis Healthcare EBIT Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Metropolis Healthcare (BOM:542650) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (BOM:542650) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

METROPOLIS:India

Address

Hind Cycle Marg, 250-D, Udyog Bhavan, Behind Glaxo, Worli, Mumbai, MH, IND, 400 030

Website

https://www.metropolisindia.com

Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare (BOM:542650) Headlines

No Headlines